PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Key Laboratory of Molecular Biology of Infectious Diseases (Chinese Ministry of Education), Department of Infectious Diseases, The Second Affiliated Hospital, Institute for Viral Hepatitis, Chongqing Medical University, Chongqing, People\'s Republic of China.\', \'Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.\', \'Department of General Surgery, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People\'s Republic of China.\', \'Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, People\'s Republic of China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/22221751.2022.2026739
?:doi
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 34989664
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all